Next-Gen ethnography to understand decision-making among diverse populations impacted by Alzheimer'sdisease and related dementias (ADRD)
下一代民族志可了解受阿尔茨海默病和相关痴呆症 (ADRD) 影响的不同人群的决策
基本信息
- 批准号:10582973
- 负责人:
- 金额:$ 9.01万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-09-15 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAwardCaregiversCaringCommunitiesConsequentialismDataDecision MakingDementiaEthnographyGoalsHealthHealthcareIndividualInstitutionInterventionMalignant NeoplasmsMedicalMedicineMethodsOutcomePatientsPopulation HeterogeneityReproducibilityResearchShapesSocial SciencesSociologycomparativeexperienceimprovednovelnovel strategiesparent grantsocialtool
项目摘要
Project Summary/Abstract (Parent Grant)
Culture is central to decision-making in health and healthcare and especially consequential in Alzheimer’s
disease and related dementias (ADRD). Culture shapes how communities of patients and caregivers
experience ADRD, and culture shapes how medical and social institutions manage ADRD. As an expert in the
sociology of culture, I have developed novel methods for the rigorous and replicable study of culture in the
context of health and medicine. To date, my research has largely focused on culture and cancer. However, in
the last three years I have become engaged in studies related to ADRD. I am applying for the NIA BSR LEADR
award to bring my expertise to the field of ADRD research. I propose a project with two goals: first, to explain
how culture shapes experiences of ADRD in diverse populations; second, to leverage this improved
understanding of culture to develop tailored decision-support for ADRD stakeholders. My proposed project
includes four activities to accomplish these goals. (1) Use comparative ethnography – a qualitative social
science approach which is a principal approach for studying culture – to examine experiences of ADRD among
diverse populations who receive care in a variety of institutional settings. (2) Develop novel methods for the
analysis and presentation of the qualitative data produced by the comparative ethnography. (3) Characterize
strategies of decision-making among diverse populations impacted by ADRD, including how community and
institutional cultures shape those strategies. (4) Propose tools that leverage new understandings of decision-
making strategies to support patient, caregiver, and clinician decision-making in diverse populations and
institutions. The outcomes of this project include new understandings of how culture shapes ADRD among
diverse populations impacted by ADRD; novel methods for gathering, analyzing, and presenting data about
culture that achieve high levels of rigor and reproducibility; and identification of new approaches and targets for
interventions to improve decision-support for individuals, communities and institutions impacted by ADRD.
项目摘要/摘要(家长资助)
文化是健康和医疗保健决策的核心,特别是在阿尔茨海默氏症中
疾病及相关痴呆(ADRD)。文化塑造了患者和护理人员的社区
经验ADRD和文化塑造了医疗和社会机构如何管理ADRD。作为一名专家,
文化社会学,我已经开发了严格的和可复制的文化研究的新方法,
健康和医学的背景。到目前为止,我的研究主要集中在文化和癌症。但在
在过去的三年里,我一直从事与ADRD相关的研究。我正在申请NIA BSR LEADR
奖,把我的专业知识,ADRD研究领域。我提出一个项目有两个目标:第一,
文化如何塑造不同人群的ADRD经历;第二,为了利用这一改善
了解文化,为ADRD利益相关者提供定制的决策支持。我提议的项目
包括四项活动来实现这些目标。(1)使用比较民族志-定性社会
科学方法是研究文化的主要方法----审查在下列国家和地区开展反种族歧视活动的经验:
在各种机构环境中接受护理的不同人群。(2)开发新的方法,
分析和介绍比较民族志产生的定性数据。(3)表征
在受严重干旱和退化所致疾病影响的不同人群中制定决策战略,包括社区和
制度文化塑造了这些战略。(4)提出利用对决策的新理解的工具-
制定策略,以支持不同人群中的患者、护理人员和临床医生的决策,
机构职能体系该项目的成果包括对文化如何塑造ADRD的新理解,
受ADRD影响的不同人群;收集、分析和呈现有关数据的新方法
培养,实现高水平的严谨性和可重复性;并确定新的方法和目标,
采取干预措施,改善对受严重急性RD影响的个人、社区和机构的决策支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Daniel P. Dohan其他文献
Daniel P. Dohan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Daniel P. Dohan', 18)}}的其他基金
Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)
领导力加强医学文化中的老龄化研究和创新(LEARN-MC)
- 批准号:
10427360 - 财政年份:2020
- 资助金额:
$ 9.01万 - 项目类别:
Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)
领导力加强医学文化中的老龄化研究和创新(LEARN-MC)
- 批准号:
10676086 - 财政年份:2020
- 资助金额:
$ 9.01万 - 项目类别:
Leadership to Enhance Aging Research and Innovation in Medical Culture (LEARN-MC)
领导力加强医学文化中的老龄化研究和创新(LEARN-MC)
- 批准号:
10224096 - 财政年份:2020
- 资助金额:
$ 9.01万 - 项目类别:
Next-Gen ethnography to understand decision-making among diverse populations impacted by Alzheimer's disease and related dementias (ADRD)
下一代民族志可了解受阿尔茨海默病和相关痴呆症 (ADRD) 影响的不同人群的决策
- 批准号:
10093953 - 财政年份:2020
- 资助金额:
$ 9.01万 - 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
- 批准号:
8658026 - 财政年份:2010
- 资助金额:
$ 9.01万 - 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
- 批准号:
8256596 - 财政年份:2010
- 资助金额:
$ 9.01万 - 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
- 批准号:
8450179 - 财政年份:2010
- 资助金额:
$ 9.01万 - 项目类别:
Before Consent: Cancer Patients' Deliberations about Early Phase Clinical Trials
同意之前:癌症患者对早期临床试验的考虑
- 批准号:
8080846 - 财政年份:2010
- 资助金额:
$ 9.01万 - 项目类别:
Poverty, Substance Use, and Stigma in Four Organizations
四个组织中的贫困、药物滥用和耻辱
- 批准号:
6941393 - 财政年份:2003
- 资助金额:
$ 9.01万 - 项目类别:
Poverty, Substance Use, and Stigma in Four Organizations
四个组织中的贫困、药物滥用和耻辱
- 批准号:
6681800 - 财政年份:2003
- 资助金额:
$ 9.01万 - 项目类别:
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 9.01万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 9.01万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 9.01万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 9.01万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 9.01万 - 项目类别: